The Role of Temporal Changes in Pain Response After Transforaminal Epidural Steroid Injection on Treatment Success

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorMarmara University

About this trial

Transforaminal epidural steroid injection (TFESI) is a commonly used minimally invasive procedure for the treatment of lumbar radicular pain secondary to disc herniation. Although TFESI has been shown to provide significant pain relief in a substantial proportion of patients, the onset, duration, and temporal pattern of pain relief after the procedure vary considerably among individuals. The relationship between early pain response patterns and long-term treatment success remains poorly understood.

This prospective observational study aims to evaluate whether temporal changes in pain intensity following TFESI, particularly during the early post-procedural period, are associated with clinical treatment success at mid- and long-term follow-up. Pain intensity will be assessed using the Numeric Rating Scale (NRS) at predefined time points following the procedure, and treatment success will be defined as a ≥50% reduction in NRS score compared with baseline.

Eligibility criteria

Qualifiers

Age between 18 and 65 years

Pre-procedural Numeric Rating Scale (NRS) pain score of 4 or higher

Presence of segmental lumbar disc herniation demonstrated on magnetic resonance imaging (MRI) consistent with clinical findings

Undergoing fluoroscopy-guided transforaminal epidural steroid injection due to insufficient response to conservative treatments, as determined by the algology clinic

Disqualifiers

Presence of spondylolisthesis, scoliosis, or lumbar spinal stenosis accompanying lumbar disc herniation

Presence of malignancy

History of lumbar spine surgery for disc herniation

Transforaminal epidural steroid injection within the previous 6 months

Trial design

Treatments tested in this trial

  • Transforaminal epidural steroid injection

Treatment groups

120 Participants
are divided into 1 treatment group

Sponsors and collaborators